Anebulo Pharmaceuticals, Inc. (ANEB) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -1.31M | -1.27M | -1.65M | -1.6M | -1.41M | -1.69M | -2.05M | -1.5M | -1.81M | -2.73M | -2.85M | -2.19M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 6.58% | 24.67% | 19.53% | -6.98% | 22.49% | 38.02% | 27.95% | 31.64% | 30.49% | -34.07% | -42.52% | -49.91% |
| Net Income | -2M | -2.16M | -2.14M | -1.68M | -2.46M | -2.2M | -1.35M | -1.65M | -2.72M | -2.48M | -2.5M | -2.8M |
| Depreciation & Amortization | 0 | 17.44K | 0 | 245.18K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 198.53K | 237.64K | 340.3K | 255.27K | 564.33K | 286.92K | 177.19K | 151.64K | 219.26K | 210.8K | 223.56K | 223.64K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 17.44K | 0 | 17.44K | 0 | 59.7K | 59.7K | 59.7K | 59.7K | 31.84K | 0 | 0 | 0 |
| Working Capital Changes | 470.23K | 630.19K | 135.03K | -426.18K | 433.26K | 164.13K | -939.85K | -55.17K | 652.56K | -456.8K | -577.23K | 383.79K |
| Change in Receivables | -46.96K | 63.39K | 0 | 0 | 214.61K | -245.36K | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -52.68K | 383.36K | -203.4K | 145.66K | 29.78K | 95.72K | -228.49K | 66.24K | -247.27K | 31.4K | -36.36K | 224.35K |
| Cash from Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 0 | 0 | 0 | -116.66K | 15M | 0 | 0 | 0 | -62.35K | 0 | -68.16K | 0 |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 0 | 0 | -116.66K | 15M | 0 | 0 | 0 | -62.35K | 0 | -68.16K | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | -1.31M | -1.27M | -1.65M | -1.72M | 13.59M | -1.69M | -2.05M | -1.5M | -1.88M | -2.73M | -2.92M | -2.19M |
| Free Cash Flow | -1.31M | -1.27M | -1.65M | -1.6M | -1.41M | -1.69M | -2.05M | -1.5M | -1.81M | -2.73M | -2.85M | -2.19M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 6.58% | 24.67% | 19.53% | -6.98% | 22.49% | 38.02% | 27.95% | 31.64% | 30.49% | -34.07% | -42.52% | -49.91% |
| FCF per Share | -0.03 | -0.03 | -0.04 | -0.06 | -0.05 | -0.07 | -0.08 | -0.06 | -0.07 | -0.11 | -0.11 | -0.09 |
| FCF Conversion (FCF/Net Income) | 0.66x | 0.59x | 0.77x | 0.96x | 0.57x | 0.77x | 1.52x | 0.91x | 0.67x | 1.10x | 1.14x | 0.78x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |